Showing 34,862 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

Women

Black Cisgender Women in the Deep South Have Distinct PrEP Delivery Preferences

Editor's pick
TheBodyPro
8 June 2022
HIV & criminal law

Canadian HIV criminalisation laws increase violence against women living with HIV

News
8 June 2022
Women

Women at high risk for HIV need higher levels of plasma tenofovir for HIV protection

Editor's pick
Healio
7 June 2022

Genetics and kidney disease – HIV update, 7 June 2022

June 2022
Treatment guidelines

World’s largest HIV treatment programme could shift almost entirely to WHO-preferred first line regimen

News
7 June 2022
Mpox (monkeypox)

aidsmapCHAT: series 5, episode 5 Video

June 2022
TB diagnosis

New blood test can help doctors diagnose tuberculosis and monitor treatment

Editor's pick
Science Daily
6 June 2022
Activism & civil society

OBEs for Terrence Higgins Trust co-founders to mark 40 years since Terry’s death

Editor's pick
Terrence Higgins Trust
6 June 2022
Mpox (monkeypox)

550… and Counting

Editor's pick
The Nation
6 June 2022
The search for a cure

Combination Anti-HIV Antibody Infusions Suppress Virus for Sustained Period

Editor's pick
HIV.gov
6 June 2022
Mpox (monkeypox)

Monkeypox DNA in semen supports using condoms for eight weeks after infection has cleared

Editor's pick
i-Base
6 June 2022
Mental & emotional health problems

People living with HIV in the UK have an increased risk of mental illness

News
6 June 2022
Resistance

Dolutegravir resistance showing up after prolonged periods on failing treatment

News
2 June 2022
Mpox (monkeypox)

UKHSA latest findings into monkeypox outbreak

Editor's pick
UK Health Security Agency (UKHSA)
1 June 2022
Support issues for children & young people

Born with HIV: disclosure during adolescence does not harm mental health

Editor's pick
Be In The Know
1 June 2022
Treatment guidelines

South Africa: Over 3 million people on new HIV drug, but not all smooth sailing

Editor's pick
Spotlight
1 June 2022
Pharmaceutical industry

GSK's ViiV adds a new, unexpected demographic to Dovato campaign

Editor's pick
FiercePharma
1 June 2022
Mpox (monkeypox)

With monkeypox, the world must heed the lessons of HIV/AIDS

Editor's pick
Al Jazeera
1 June 2022
Ageing & HIV

Fatigue Affects Cognitive Processing in the Ageing HIV Population

Editor's pick
Medscape (requires free registration)
1 June 2022
Government, leadership & policy

Why we need to push health equity for LGBTI+ communities into the spotlight

Editor's pick
POLITICO
1 June 2022
Government, leadership & policy

The HIV Action Plan for England: six months on

Editor's pick
Terrence Higgins Trust
1 June 2022
Ethnic & cultural minorities

Black British people with HIV and APOL1 gene variants are more likely to develop kidney failure

News
1 June 2022
Mpox (monkeypox)

BHIVA rapid statement on monkeypox virus

Editor's pick
British HIV Association (BHIVA)
31 May 2022
Drug interactions & pharmacokinetics

ViiV Healthcare has obtained marketing approval for the first and only complete long-acting treatment for HIV in Japan

Editor's pick
ViiV press release
31 May 2022